{
  "symbol": "GILD",
  "year": 2024,
  "Period": "Q2",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.0825,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.384
  },
  "top_positive": [
    {
      "sent": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (unaudited) Three Months Ended June 30, 2024 (in millions, except per share amounts) Gilead Stockholders\u2019 Equity Noncontrolling Interest Total Stockholders\u2019 Equity Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income Retained Earnings Shares Amount Balance as of March 31, 2024 1,246 $ 1 $ 6,813 $ 69 $ 10,656 $ ( 84 ) $ 17,455 Net income \u2014 \u2014 \u2014 \u2014 1,614 \u2014 1,614 Other comprehensive income, net \u2014 \u2014 \u2014 24 \u2014 \u2014 24 Issuances under equity incentive plans 2 \u2014 5 \u2014 \u2014 \u2014 5 Stock-based compensation \u2014 \u2014 209 \u2014 \u2014 \u2014 209 Repurchases of common stock under repurchase programs ($ 66.67 average price per share) ( 2 ) \u2014 ( 6 ) \u2014 ( 94 ) \u2014 ( 100 ) Repurchases of common stock for employee tax withholding under equity incentive plans and other ( 1 ) \u2014 \u2014 \u2014 ( 33 ) \u2014 ( 33 ) Dividends declared ($ 0.77 ) \u2014 \u2014 \u2014 \u2014 ( 978 ) \u2014 ( 978 ) Balance as of June 30, 2024 1,246 $ 1 $ 7,022 $ 93 $ 11,165 $ ( 84 ) $ 18,197 Six Months Ended June 30, 2024 (in millions, except per share amounts) Gilead Stockholders\u2019 Equity Noncontrolling Interest Total Stockholders\u2019 Equity Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income Retained Earnings Shares Amount Balance as of December 31, 2023 1,246 $ 1 $ 6,500 $ 28 $ 16,304 $ ( 84 ) $ 22,749 Net loss \u2014 \u2014 \u2014 \u2014 ( 2,556 ) \u2014 ( 2,556 ) Other comprehensive income, net \u2014 \u2014 \u2014 65 \u2014 \u2014 65 Issuances under employee stock purchase plan 1 \u2014 80 \u2014 \u2014 \u2014 80 Issuances under equity incentive plans 7 \u2014 70 \u2014 \u2014 \u2014 70 Stock-based compensation \u2014 \u2014 397 \u2014 \u2014 \u2014 397 Repurchases of common stock under repu\n: (in millions) December 31, 2023 Cash and cash equivalents $ 83 Short-term marketable debt securities 1,179 Long-term marketable debt securities 1,163 Total $ 2,426 14 Equity Securities The following table summarizes the classification of our equity securities on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2024 December 31, 2023 Equity securities measured at fair value: Cash and cash equivalents $ 1,525 $ 4,465 Prepaid and other current assets 1,426 1,086 Other long-term assets 330 656 Equity method investments and other equity investments without readily determinable fair values: Other long-term assets 376 $ 340 Total $ 3,657 $ 6,547 For our equity method investments in Galapagos and Arcus Biosciences, Inc.",
      "score": 0.9894
    },
    {
      "sent": "(2) 3.1 Restated Certificate of Incorporation of Registrant (3) 3.2 Amended and Restated Bylaws of Registrant 4.1 Reference is made to Exhibit 3.1 and Exhibit 3.2 (4) 4.2 Indenture related to Senior Notes, dated as of March\u00a030, 2011, between Registrant and Wells Fargo, National Association, as Trustee (4) 4.3 First Supplemental Indenture related to Senior Notes, dated as of March 30, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including form of Senior Notes) (5) 4.4 Second Supplemental Indenture related to Senior Notes, dated as of December 13, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2041 Note) (6) 4.5 Third Supplemental Indenture related to Senior Notes, dated as of March 7, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2024 Note and Form of 2044 Note) (7) 4.6 Fourth Supplemental Indenture related to Senior Notes, dated as of November 17, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2025 Note and Form of 2045 Note) (8) 4.7 Fifth Supplemental Indenture, dated as of September 14, 2015, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2026 Note, Form of 2035 Note and Form of 2046 Note) (9) 4.8 Sixth Supplemental Indenture, dated as of September 20, 2016, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2036 Note and Form of 2047 Note) 10 4.9 Eighth Supplemental Indenture, dated as of September 30, 2020, between the Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2030 Note, Form of 2040 Note, and Form of 2050 Note) (11) 4.10 Ninth Supplemental Indenture, dated as of September 14, 2023, between the Registrant and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee (including Form of 2033 Note and Form of 2053 Note) (12) 4.11 Description of Registrant\u2019s Securities (13) 10.1* Gilead Sciences, Inc.",
      "score": 0.9854
    },
    {
      "sent": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) Three Months Ended Six Months Ended June 30, June 30, (in millions) 2024 2023 2024 2023 Net income (loss) $ 1,614 $ 1,039 $ ( 2,556 ) $ 2,024 Other comprehensive income, net: Net foreign currency translation gain (loss) 1 37 ( 16 ) 32 Available-for-sale debt securities: Net unrealized (loss) gain, net of tax impact of $ 0 , $ 0 , $ 0 and $ 0 , respectively \u2014 ( 3 ) \u2014 6 Reclassifications to net income (loss), net of tax impact of $ 0 , $ 0 , $ 0 and $ 0 , respectively \u2014 1 5 1 Net change \u2014 ( 2 ) 5 7 Cash flow hedges: Net unrealized gain (loss), net of tax impact of $ 4 , $ 1 , $ 11 and $ 0 , respectively 28 5 81 ( 1 ) Reclassifications to net income (loss), net of tax impact of $ 1 , $ 1 , $ 1 and $ 4 , respectively ( 5 ) ( 9 ) ( 5 ) ( 29 ) Net change 23 ( 4 ) 77 ( 30 ) Other comprehensive income, net 24 31 65 9 Comprehensive income (loss), net 1,639 1,070 ( 2,491 ) 2,032 Comprehensive loss attributable to noncontrolling interest, net \u2014 ( 6 ) \u2014 ( 32 ) Comprehensive income (loss) attributable to Gilead, net $ 1,639 $ 1,076 $ ( 2,491 ) $ 2,064 See accompanying notes.",
      "score": 0.9816
    }
  ],
  "top_negative": [
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, flood or fire, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.9313
    },
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, flood or fire, equipment failure or other difficulty, may negatively i\nhere we believe commercialization will be difficult relative to other opportunities in our pipeline.",
      "score": -0.93
    },
    {
      "sent": "\u2022 Political instability or disruption in a geographic region where we operate, regardless of cause, including war, terrorism, social unrest and political changes, including in China, Russia, Ukraine, Israel and surrounding areas.",
      "score": -0.9001
    }
  ],
  "forward_snippets": [
    "(\u201cArcus\u201d), we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
    "Although we cannot predict with certainty the ultimate outcome of each of these litigation matters, we believe that the U.S.",
    "While we intend to vigorously oppose the appeal and defend against the Phase II claims, we cannot predict the ultimate outcome.",
    "While we intend to vigorously oppose the appeal and defend against the Phase II claims, we cannot predict the ultimate outcome.",
    "We intend to vigorously defend ourselves in these actions, however, we cannot predict the ultimate outcome."
  ],
  "curated_text": "Symbol: GILD. Year: 2024. Period: Q2. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (unaudited) Three Months Ended June 30, 2024 (in millions, except per share amounts) Gilead Stockholders\u2019 Equity Noncontrolling Interest Total Stockholders\u2019 Equity Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income Retained Earnings Shares Amount Balance as of March 31, 2024 1,246 $ 1 $ 6,813 $ 69 $ 10,656 $ ( 84 ) $ 17,455 Net income \u2014 \u2014 \u2014 \u2014 1,614 \u2014 1,614 Other comprehensive income, net \u2014 \u2014 \u2014 24 \u2014 \u2014 24 Issuances under equity incentive plans 2 \u2014 5 \u2014 \u2014 \u2014 5 Stock-based compensation \u2014 \u2014 209 \u2014 \u2014 \u2014 209 Repurchases of common stock under repurchase programs ($ 66.67 average price per share) ( 2 ) \u2014 ( 6 ) \u2014 ( 94 ) \u2014 ( 100 ) Repurchases of common stock for employee tax withholding under equity incentive plans and other ( 1 ) \u2014 \u2014 \u2014 ( 33 ) \u2014 ( 33 ) Dividends declared ($ 0.77 ) \u2014 \u2014 \u2014 \u2014 ( 978 ) \u2014 ( 978 ) Balance as of June 30, 2024 1,246 $ 1 $ 7,022 $ 93 $ 11,165 $ ( 84 ) $ 18,197 Six Months Ended June 30, 2024 (in millions, except per share amounts) Gilead Stockholders\u2019 Equity Noncontrolling Interest Total Stockholders\u2019 Equity Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income Retained Earnings Shares Amount Balance as of December 31, 2023 1,246 $ 1 $ 6,500 $ 28 $ 16,304 $ ( 84 ) $ 22,749 Net loss \u2014 \u2014 \u2014 \u2014 ( 2,556 ) \u2014 ( 2,556 ) Other comprehensive income, net \u2014 \u2014 \u2014 65 \u2014 \u2014 65 Issuances under employee stock purchase plan 1 \u2014 80 \u2014 \u2014 \u2014 80 Issuances under equity incentive plans 7 \u2014 70 \u2014 \u2014 \u2014 70 Stock-based compensation \u2014 \u2014 397 \u2014 \u2014 \u2014 397 Repurchases of common stock under repu\n: (in millions) December 31, 2023 Cash and cash equivalents $ 83 Short-term marketable debt securities 1,179 Long-term marketable debt securities 1,163 Total $ 2,426 14 Equity Securities The following table summarizes the classification of our equity securities on our Condensed Consolidated Balance Sheets: (in millions) June 30, 2024 December 31, 2023 Equity securities measured at fair value: Cash and cash equivalents $ 1,525 $ 4,465 Prepaid and other current assets 1,426 1,086 Other long-term assets 330 656 Equity method investments and other equity investments without readily determinable fair values: Other long-term assets 376 $ 340 Total $ 3,657 $ 6,547 For our equity method investments in Galapagos and Arcus Biosciences, Inc. (2) 3.1 Restated Certificate of Incorporation of Registrant (3) 3.2 Amended and Restated Bylaws of Registrant 4.1 Reference is made to Exhibit 3.1 and Exhibit 3.2 (4) 4.2 Indenture related to Senior Notes, dated as of March\u00a030, 2011, between Registrant and Wells Fargo, National Association, as Trustee (4) 4.3 First Supplemental Indenture related to Senior Notes, dated as of March 30, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including form of Senior Notes) (5) 4.4 Second Supplemental Indenture related to Senior Notes, dated as of December 13, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2041 Note) (6) 4.5 Third Supplemental Indenture related to Senior Notes, dated as of March 7, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2024 Note and Form of 2044 Note) (7) 4.6 Fourth Supplemental Indenture related to Senior Notes, dated as of November 17, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2025 Note and Form of 2045 Note) (8) 4.7 Fifth Supplemental Indenture, dated as of September 14, 2015, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2026 Note, Form of 2035 Note and Form of 2046 Note) (9) 4.8 Sixth Supplemental Indenture, dated as of September 20, 2016, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2036 Note and Form of 2047 Note) 10 4.9 Eighth Supplemental Indenture, dated as of September 30, 2020, between the Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2030 Note, Form of 2040 Note, and Form of 2050 Note) (11) 4.10 Ninth Supplemental Indenture, dated as of September 14, 2023, between the Registrant and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee (including Form of 2033 Note and Form of 2053 Note) (12) 4.11 Description of Registrant\u2019s Securities (13) 10.1* Gilead Sciences, Inc. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) Three Months Ended Six Months Ended June 30, June 30, (in millions) 2024 2023 2024 2023 Net income (loss) $ 1,614 $ 1,039 $ ( 2,556 ) $ 2,024 Other comprehensive income, net: Net foreign currency translation gain (loss) 1 37 ( 16 ) 32 Available-for-sale debt securities: Net unrealized (loss) gain, net of tax impact of $ 0 , $ 0 , $ 0 and $ 0 , respectively \u2014 ( 3 ) \u2014 6 Reclassifications to net income (loss), net of tax impact of $ 0 , $ 0 , $ 0 and $ 0 , respectively \u2014 1 5 1 Net change \u2014 ( 2 ) 5 7 Cash flow hedges: Net unrealized gain (loss), net of tax impact of $ 4 , $ 1 , $ 11 and $ 0 , respectively 28 5 81 ( 1 ) Reclassifications to net income (loss), net of tax impact of $ 1 , $ 1 , $ 1 and $ 4 , respectively ( 5 ) ( 9 ) ( 5 ) ( 29 ) Net change 23 ( 4 ) 77 ( 30 ) Other comprehensive income, net 24 31 65 9 Comprehensive income (loss), net 1,639 1,070 ( 2,491 ) 2,032 Comprehensive loss attributable to noncontrolling interest, net \u2014 ( 6 ) \u2014 ( 32 ) Comprehensive income (loss) attributable to Gilead, net $ 1,639 $ 1,076 $ ( 2,491 ) $ 2,064 See accompanying notes. Top negative sentences: Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, flood or fire, equipment failure or other difficulty, may negatively impact our development and commercialization efforts. Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, flood or fire, equipment failure or other difficulty, may negatively i\nhere we believe commercialization will be difficult relative to other opportunities in our pipeline. \u2022 Political instability or disruption in a geographic region where we operate, regardless of cause, including war, terrorism, social unrest and political changes, including in China, Russia, Ukraine, Israel and surrounding areas. Forward-looking snippets: (\u201cArcus\u201d), we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments. Although we cannot predict with certainty the ultimate outcome of each of these litigation matters, we believe that the U.S. While we intend to vigorously oppose the appeal and defend against the Phase II claims, we cannot predict the ultimate outcome. While we intend to vigorously oppose the appeal and defend against the Phase II claims, we cannot predict the ultimate outcome. We intend to vigorously defend ourselves in these actions, however, we cannot predict the ultimate outcome."
}